Special SiteSell Promotion

Home | Health & Fitness | Addiction

NEED ONLINE LOANS?? - Apply for Loans Online today - Click Here!

Chantix: Say No to Smoking

Addiction article brought to you by Michaellucas, Posted on: 2007-08-31   --><--

Click here to get FREE Satellite TV on your PC!

 
 

NEED ONLINE LOANS? - Apply for Loans Online today - Click Here!

For most people, smoking is both a physical and behavioral obsession. It is the major cause of many health concerns like cancer in the different parts of body, coronary disease, ulcers in the stomach, lung disease such as emphysema, impotence in men and fertility problem in women etc and heart risk is another important concern. And it is reported that more cancer deaths in the United Kingdom can be attributed to smoking tobacco than to any other single risk factor.

Although smoking is one habit difficult to kick off. But if you are bent on quitting smoking, Chantix (Varenicline) can make your Quit Smoking effort very easy. According to the study, Chantix helped 14% of subjects kick-off the smoking habit on a long-term basis or permanently. That's nearly three times the rate of those who got the panacea.

Chantix (Varenicline) was approved by the Food and Drug Administration (FDA) in 2006 for adult smokers who want to stop smoking. Chantix (Varenicline), the latest smoking cessation pill is all bound to attain a special status among the anti-smoking drug group, as it is seen to be the most efficient fighter against the menace so far. Besides that, Chantix works by stimulating the release of low levels of dopamine in your brain to help reduce the signs and symptoms of withdrawal. In addition, Chantix blocks nicotine receptors in your brain. So if you lapse and have a cigarette, your cigarette will not stimulate your brain's receptors the way it did in the past.

Furthermore, “the approved course of Chantix treatment is 12 weeks, a period that can be doubled in patients who successfully quit to increase the likelihood they will remain smoke-free”, the FDA said. Other clinical trials show the drug's effect is more pronounced in the short-term: 44 percent of patients quit smoking following a 12-week course of treatment with Chantix, compared to the 30 percent of Zyban patients who quit, according to Pfizer. However, smoking cessation experts said the longer-term data are more applicable, given the difficulty of quitting the habit for good.

But on the other hand; in clinical trials, the most common adverse effects of Chantix was nausea, headache, vomiting, flatulence (gas), insomnia, abnormal dreams, and dysgeusia (change in taste perception). In addition, when you stop smoking, your body will need time to adjust to the absence of nicotine. You may feel side effects from the anti smocking pills. So, it is advised to get guidance from your doctor to avoid such complications.

To end with, it can be said that Chantix is not a magic pill, but it has sufficiently proved itself as an effective quit smoking drug. Therefore, your best chance to quit smoking is with Chantix, but you must be committed to your goal.

This Addiction article is provided by Articleteller - The Free Article Directory http://www.articleteller.com

Michael Lucas is the pioneer author and like to share his experience and ideas with others.If you want more information about Chantix you can visit www.e-pillsstore.com

Christian Singles Free Trial

Click here to get FREE Satellite TV on your PC!



Please Rate this Addiction Article

Chantix: Say No to Smoking

 

Not yet Rated

Click the XML Icon Above to Receive Addiction Articles Via RSS!


Special SiteSell Promotion


NEED ONLINE LOANS?? - Apply for Loans Online today - Click Here!


Français Espanol ??? [?????] Italiano Deutsch ?? ?? Nederlands ??? Port?????? ????????
Swedish Indo Romanian Polish Norwegian Hindi Finnish Danish Czech Croatian Bulgarian English - Original language
Translation by: website translator





Check out Our Friendly Links

Winning the Search Engine Wars
Bankruptcy Faqs
Car Insurance
Cash Advance
Debt Counseling

© 2006 Articleteller.com All Rights Reserved. Sitemap1 | Sitemap2 | Sitemap3
Use of our service is protected by our Privacy Policy and Terms of Service





















Powered by Article Dashboard